Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

LeMaitre Vascular Stock News

LMATNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$82.82

1.461.79%

At close: -

$82.82

0.000.00%

After Hours: 4:00 PM EDT

LeMaitre Vascular (LMAT) Forecast

News

Earnings LeMaitre Vascular (LMAT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest LeMaitre Vascular Stock News | NASDAQ:LMAT | Benzinga

Get the latest news on LeMaitre Vascular stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on LeMaitre Vascular performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, February 28, 2025

Lake Street Maintains Buy on LeMaitre Vascula...
Benzinga Newsdesk - Feb 28, 2025, 12:01PM
Citizens Capital Markets Maintains Buy on LeM...
Benzinga Newsdesk - Feb 28, 2025, 10:54AM
LeMaitre Vascular shares are trading lower af...
Benzinga Newsdesk - Feb 28, 2025, 8:22AM
Barrington Research Downgrades LeMaitre Vascu...
Benzinga Newsdesk - Feb 28, 2025, 7:43AM

Thursday, February 27, 2025

LeMaitre Vascular shares are trading lower af...
Benzinga Newsdesk - Feb 27, 2025, 4:43PM
LeMaitre Vascular Q4 2024 Adj. EPS $0.49, Inl...
Benzinga Newsdesk - Feb 27, 2025, 4:27PM
Earnings Scheduled For February 27, 2025
Benzinga Insights - Feb 27, 2025, 3:32AM

Thursday, February 13, 2025

Wells Fargo Initiates Coverage On LeMaitre Va...
Benzinga Newsdesk - Feb 13, 2025, 10:03AM
LeMaitre Vascular Appointed As CFO, Effective...
Benzinga Newsdesk - Feb 13, 2025, 9:05AM

Tuesday, December 17, 2024

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Dec 17, 2024, 4:05PM
Reported Earlier, LeMaitre Vascular Announces...
Benzinga Newsdesk - Dec 17, 2024, 1:51AM

Monday, December 16, 2024

LeMaitre Vascular Announces Proposed $150M Ag...
Benzinga Newsdesk - Dec 16, 2024, 8:01AM

Thursday, November 28, 2024

Strategic Sale: James John OConnor Decides To Exercise Options Worth $527K At LeMaitre Vascular
Benzinga Insights - Nov 28, 2024, 10:02AM

Wednesday, November 27, 2024

Witnessing An Insider Decision, George LeMaitre Exercises Options Valued At $187K At LeMaitre Vascular
Benzinga Insights - Nov 27, 2024, 10:03AM

Wednesday, November 20, 2024

Bridget Ross At LeMaitre Vascular Decides to Exercises Options Worth $276K
Benzinga Insights - Nov 20, 2024, 10:00AM

Friday, November 01, 2024

LeMaitre Vascular shares are trading higher a...
Benzinga Newsdesk - Nov 1, 2024, 3:57PM
Oppenheimer Reiterates Outperform on LeMaitre...
Benzinga Newsdesk - Nov 1, 2024, 12:50PM
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor - Nov 1, 2024, 12:13PM
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular
Benzinga Insights - Nov 1, 2024, 12:00PM
Barrington Research Maintains Outperform on L...
Benzinga Newsdesk - Nov 1, 2024, 11:31AM

Thursday, October 31, 2024

LeMaitre Vascular Raises FY2024 GAAP EPS Guid...
Benzinga Newsdesk - Oct 31, 2024, 4:15PM
LeMaitre Vascular Q3 2024 GAAP EPS $0.49 Beat...
Benzinga Newsdesk - Oct 31, 2024, 4:09PM

Tuesday, October 15, 2024

This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Avi Kapoor - Oct 15, 2024, 9:34AM
Analyst Scoreboard: 4 Ratings For LeMaitre Vascular
Benzinga Insights - Oct 15, 2024, 8:02AM
Cantor Fitzgerald Initiates Coverage On LeMai...
Benzinga Newsdesk - Oct 15, 2024, 7:23AM

Friday, September 20, 2024

Barrington Research Maintains Outperform on L...
Benzinga Newsdesk - Sep 20, 2024, 11:20AM

Wednesday, August 28, 2024

Acadia Healthcare Expands Behavioral Health Services in Iowa
Zacks - Aug 28, 2024, 4:06PM

Monday, August 26, 2024

Lemaitre Vascular Announces Joseph P. Pellegr...
Benzinga Newsdesk - Aug 26, 2024, 4:17PM

Tuesday, August 20, 2024

JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk - Aug 20, 2024, 7:57AM

Friday, August 02, 2024

Barrington Research Maintains Outperform on L...
Benzinga Newsdesk - Aug 2, 2024, 6:07PM

Thursday, August 01, 2024

LeMaitre Vascular Sees Q3 EPS $0.42-$0.46 Vs ...
Benzinga Newsdesk - Aug 1, 2024, 5:36PM
LeMaitre Vascular Q2 2024 GAAP EPS $0.53 Beat...
Benzinga Newsdesk - Aug 1, 2024, 5:04PM

Wednesday, June 26, 2024

GE HealthCare's New Tie-Up to Boost CVD Workflow
Zacks - Jun 26, 2024, 12:05PM

Friday, May 31, 2024

Navigating 4 Analyst Ratings For LeMaitre Vascular
Benzinga Insights - May 31, 2024, 10:00AM
Roth MKM Reinstates Buy on LeMaitre Vascular,...
Benzinga Newsdesk - May 31, 2024, 6:01AM

Friday, May 03, 2024

Barrington Research Maintains Outperform on L...
Benzinga Newsdesk - May 3, 2024, 4:44PM
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk - May 3, 2024, 3:09PM
LeMaitre Vascular shares are trading higher a...
Benzinga Newsdesk - May 3, 2024, 11:44AM

Thursday, May 02, 2024

LeMaitre Vascular Sees Q2 EPS $0.45-$0.50 vs ...
Benzinga Newsdesk - May 2, 2024, 5:42PM
LeMaitre Vascular Q1 2024 GAAP EPS $0.44 Beat...
Benzinga Newsdesk - May 2, 2024, 5:06PM

Friday, April 26, 2024

Stifel Upgrades LeMaitre Vascular to Buy, Rai...
Benzinga Newsdesk - Apr 26, 2024, 6:06AM

Wednesday, March 27, 2024

Engaging In Options Activity, George LeMaitre Exercises Options Valued At $266K In LeMaitre Vascular
Benzinga Insights - Mar 27, 2024, 11:00AM

Tuesday, March 05, 2024

Insider Transaction: George LeMaitre Sells $6.94M Worth Of LeMaitre Vascular Shares
Benzinga Insights - Mar 5, 2024, 10:01AM
Strategic Sale: Joseph Pellegrino JR Decides To Exercise Options Worth $1.08M At LeMaitre Vascular
Benzinga Insights - Mar 5, 2024, 10:01AM

Wednesday, February 28, 2024

Barrington Research Maintains Outperform Rating for LeMaitre Vascular: Here's What You Need To Know
Benzinga Insights - Feb 28, 2024, 12:00PM
LeMaitre Vascular shares are trading higher a...
Benzinga Newsdesk - Feb 28, 2024, 11:41AM
Barrington Research Maintains Outperform on L...
Benzinga Newsdesk - Feb 28, 2024, 11:36AM

Tuesday, February 27, 2024

LeMaitre Vascular Sees Q1 EPS $0.36-$0.41 vs ...
Benzinga Newsdesk - Feb 27, 2024, 5:39PM
Recap: LeMaitre Vascular Q4 Earnings
Benzinga Insights - Feb 27, 2024, 4:45PM
LeMaitre Vascular Q4 2023 GAAP EPS $0.38 Beat...
Benzinga Newsdesk - Feb 27, 2024, 4:42PM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved